AMENDMENT TO RFA-AI-02-031:  REGIONAL CENTERS OF EXCELLENCE FOR BIODEFENSE 
AND EMERGING INFECTIOUS DISEASES RESEARCH (RCE)

Release Date:  September 17, 2002

NOTICE:  NOT-AI-02-051

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)

The purpose is to clarify certain aspects of RFA AI-02-031 which was 
published in the NIH Guide August 2, 2002,: 
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-02-031.html
All other aspects of the RFA remain unchanged.

o  Into the section FUNDS AVAILABLE insert, after the first sentence, the 
following statement:  "Given the total funds available for the program, it is 
anticipated that awards will be made in the general range of $4-6 million, 
direct costs, per year."

o  In several places the RFA refers to the CDC Category A-C list of agents.  
These statements should, instead, refer to the NIAID Category A, B & C 
Priority Pathogens list which may be found at: 
http://www2.niaid.nih.gov/Biodefense/bandc_priority.htm

o  Into the section ELIGIBLE INSTITUTIONS insert the following statement:  
"An application may be submitted from a consortium that includes participants 
from more than one region."

o  Into the section ELIGIBLE INSTITUTIONS insert the following statement:  
"Applications will not be accepted from institutions that are submitting 
applications to the Planning Grants for Regional Centers of Excellence for 
Biodefense and Emerging Infectious Diseases Research (P-RCE) program (AI-02-
050)."

o  From the section INDIVIDUALS ELIGIBLE TO BECOME PRINCIPAL INVESTIGATORS 
delete the following statement:  "Principal Investigators must be United 
States citizens.  All investigators in RCE activities who handle CDC Category 
A Agents must be United States citizens."  Potential applicants are advised 
to consult the CDC and NIAID websites for guidance about select agents and 
issues related to the Patriot Act.

Q&As and additional information relating to this Notice and the RCE program 
may be accessed at:  http://www2.niaid.nih.gov/Biodefense/rblrce/qanda.htm

INQUIRIES

Inquiries regarding this notice may be directed to:

Dr. Rona Hirschberg
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infections Diseases  
6700B Rockledge Drive, Room 3129, MSC 7630
Bethesda, MD  20892-7630
Zip code for express couriers: 20817 
Telephone  (301) 496-1884
Fax:  (301) 480-4528
e-mail:  [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®